急性白血病控制障碍会议。交叉耐药性与侧支敏感性研究（1962 - 1964年） - Suppr

Suppr

超能文献

Conference on obstacles to the control of acute leukemia. Studies on cross-resistance and collateral sensitivity (1962-1964).

作者信息

Hutchison D J

出版信息

Cancer Res. 1965 Oct;25(9):1581-95.

PMID:5323968

Abstract

摘要

相似文献

Conference on obstacles to the control of acute leukemia. Studies on cross-resistance and collateral sensitivity (1962-1964).急性白血病控制障碍会议。交叉耐药性与侧支敏感性研究（1962 - 1964年）

Cancer Res. 1965 Oct;25(9):1581-95.

Elevated DNA polymerase alpha, DNA polymerase beta, and DNA topoisomerase II in a melphalan-resistant rhabdomyosarcoma xenograft that is cross-resistant to nitrosoureas and topotecan.在一株对美法仑耐药且对亚硝基脲和拓扑替康交叉耐药的横纹肌肉瘤异种移植瘤中，DNA聚合酶α、DNA聚合酶β和DNA拓扑异构酶II水平升高。

Cancer Res. 1994 Jul 1;54(13):3487-93.

Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia.儿童白血病中γ-肌动蛋白和微管蛋白靶向耐药性的改变。

J Natl Cancer Inst. 2006 Oct 4;98(19):1363-74. doi: 10.1093/jnci/djj372.

Characterization of four drug-resistant P388 sublines: resistance/sensitivity in vivo, resistance-and proliferation-markers, immunogenicity.

Anticancer Res. 1994 Sep-Oct;14(5A):1995-2003.

Murine leukemia L1210 cell lines with different patterns of resistance to platinum coordination complexes.

Cancer Treat Rep. 1984 Sep;68(9):1189-90.

Conference on obstacles to the control of acute leukemia. Formal discussion: immunologic aspects.急性白血病控制障碍会议。正式讨论：免疫学方面。

Cancer Res. 1965 Oct;25(9):1479-80.

Conference on obstacles to the control of acute leukemia. Formal discussion: biologic aspects.急性白血病控制障碍会议。正式讨论：生物学方面。

Cancer Res. 1965 Oct;25(9):1477-8.

Conference on obstacles to the control of acute leukemia. Formal discussion: some reflections on the basis of drug failures.急性白血病控制障碍会议。正式讨论：基于药物治疗失败的一些思考。

Cancer Res. 1965 Oct;25(9):1551-2.

Dihydrodiol dehydrogenase in drug resistance and sensitivity of human carcinomas.二氢二醇脱氢酶与人类癌症的耐药性和敏感性

Cancer Chemother Pharmacol. 2007 Apr;59(5):697-702. doi: 10.1007/s00280-006-0351-1. Epub 2006 Sep 29.

Establishment of cross-resistance profiles for new agents.建立新型药物的交叉耐药谱。

Cancer Treat Rep. 1983 Oct;67(10):905-22.

引用本文的文献

A curative combination cancer therapy achieves high fractional cell killing through low cross-resistance and drug additivity.一种有治疗作用的联合癌症疗法通过低交叉耐药性和药物协同作用实现高分数细胞杀伤。

Elife. 2019 Nov 19;8:e50036. doi: 10.7554/eLife.50036.

Cross-drug resistance to sunitinib induced by doxorubicin in endothelial cells.阿霉素在内皮细胞中诱导产生的对舒尼替尼的交叉耐药性。

Oncol Lett. 2015 Mar;9(3):1287-1292. doi: 10.3892/ol.2014.2819. Epub 2014 Dec 22.

Inherent and acquired resistance to paclitaxel in hepatocellular carcinoma: molecular events involved.肝癌对紫杉醇的固有和获得性耐药：涉及的分子事件。

PLoS One. 2013 Apr 16;8(4):e61524. doi: 10.1371/journal.pone.0061524. Print 2013.

Collateral sensitivity of a methotrexate-resistant L1210 cell line to the vinca alkaloids.甲氨蝶呤耐药L1210细胞系对长春花生物碱的 collateral敏感性。（注：这里collateral根据语境可能不太好准确翻译，或许是“旁系”之类的意思，但直接保留英文更合适，因为不确定准确含义）

Cancer Chemother Pharmacol. 1984;13(1):43-6. doi: 10.1007/BF00401446.

Cyclophosphamide-resistant Yoshida ascites tumor cells and their cross resistance to some alkylating agents.环磷酰胺耐药的吉田腹水瘤细胞及其对某些烷化剂的交叉耐药性。

J Cancer Res Clin Oncol. 1979 Jul 27;94(3):257-63. doi: 10.1007/BF00419285.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验